HMGB1: The metabolic weapon in the arsenal of NK cells
Related Experiment Video
Updated: Mar 14, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Adelheid Cerwenka1, Jürgen Kopitz2, Peter Schirmacher2
1German Cancer Research Center, Research Group Innate Immunity , Heidelberg, Germany.
Abstract:
Targeting tumor glycolysis would hit the main energy source of cancer. We show that natural killer (NK) cells pursue this strategy by employing high mobility group box 1 (HMGB1) protein-a well-known proinflammatory cytokine-to specifically target glycolysis in cancer cells. This opens up new perspectives for cancer immunotherapy.
Insights
Natural killer (NK) cells target cancer's energy source using high mobility group box 1 (HMGB1) protein. This novel approach inhibits tumor glycolysis, offering new avenues for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Metabolic Pathways
Background:
- Cancer cells rely heavily on glycolysis for energy.
- Targeting tumor metabolism is a promising therapeutic strategy.
- Natural killer (NK) cells are crucial immune components in cancer surveillance.
Purpose of the Study:
- To investigate the role of NK cells in targeting tumor glycolysis.
- To explore the mechanism by which NK cells inhibit cancer cell metabolism.
- To evaluate the potential of NK cell-mediated targeting of glycolysis in cancer immunotherapy.
Main Methods:
- Analysis of NK cell activity against cancer cells.
- Investigation of high mobility group box 1 (HMGB1) protein function.
- Assessment of glycolytic rates in cancer cells.
- In vitro and in vivo cancer models.
Main Results:
- NK cells were found to specifically target tumor glycolysis.
- High mobility group box 1 (HMGB1) protein mediates this effect.
- Inhibition of glycolysis by NK cells suppressed cancer cell growth.
Conclusions:
- NK cells utilize HMGB1 to target and inhibit cancer cell glycolysis.
- This mechanism represents a novel strategy for cancer immunotherapy.
- Targeting tumor glycolysis via NK cells opens new therapeutic perspectives.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

